Scientific Program Partner
Meeting agenda created in conjunction with The Antibody Society.
Marriott Marquis San Diego,
Live In-Person Event: December 15 - 18, 2024
THE #1 ANTIBODY ENGINEERING CONFERENCE FOR ACCELERATING NEXT GENERATION ANTIBODIES TO COMMERCIAL SUCCESS
The latest science and research on antibody engineering, design and selection diving into critical topics including Neurodegenerative Diseases, Tumor Microenvironment in Antibody Therapy, Antibody Immune Agonist, Bi-Specifics, ADCs, Protein-Based Degraders, Immuno-oncology, T-Cells, VHH and much more...
Register your interest for the 2024 event to get first access to the agenda!
Call for Speakers
EXTENDED: Submit your speaker proposal by May 24!
We are looking for presentations in the following topic areas:
- Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
- Quantitative Systems Pharmacology in Antibody Development
- Forward and Reverse Translation Medicine
- Emerging In Vitro Approaches to Antibody Discovery
- Advanced In Vivo Antibody Discovery (i.e. repertoires, single cell, antigens/tolerance, immunizations, etc.)
- Novel Bispecific and Multi-specific Antibodies
- Unusual Antibody Formats
- Emerging Technologies for Antibody-Drug Conjugates (including radioisotypes and non-cytotoxic payloads)
- Innovative Concepts in Cell Engagers (incl. co-stim, and cell therapy)
- Antibody-Based Degraders for Therapeutic Development
- Antibody-Based Approaches to Treat Autoimmunity
- Antibodies for Metabolic Disease and Neurodegeneration
Get the Latest Event Updates
About the Antibody Society
The Antibody Society is an international, non-profit trade association serving individuals and organizations involved in antibody-related research and development. We research and analyze data on targeted therapeutics developed by the biopharmaceutical industry, and distribute our results and commentary via the Society’s website, presentations and publications. The Society hosts educational webinars and Symposia, and serves as the home for the Adaptive Immune Receptor Repertoire (AIRR) Community, which focuses on the generation, use, sharing and standardization of next-generation sequencing of antibodies and T cell receptors. In addition, we engage with international agencies on matters of importance to the antibody community.
Our members serve as the Scientific Advisors for the Antibody Engineering & Therapeutics conferences. The scientific programs for the meetings are designed by our Meetings Committee.
Put Yourself Infront Of Key Antibody Decision-Makers!
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact Blake Shuka: BShuka@informaconnectls.com
